Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A Randomized Trial of lu af28996 dh1 to Reduce Motor Fluctuations in Adults with Parkinson’s Disease

    Not yet recruiting

    2 1
    Czechia France Germany Italy Poland Spain +1
  • Study of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease

    Not yet recruiting

    2 1
    France Germany The Netherlands Spain
  • Effect of botulinum toxin type A – haemagglutinin complex on refractory upper‑limb resting tremor in Parkinson disease patients (drug‑combination study)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Efficacy of intravenous prasinezumab versus placebo in Parkinson’s disease patients with severe GBA mutation: a 104‑week randomized double‑blind study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France Germany Italy Luxembourg Spain Sweden
  • Cognitive effects of a three‑month methylphenidate course in Parkinson’s disease patients with mild cognitive impairment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Spain
  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Safety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson’s disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    Norway
  • A study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson’s disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Poland
  • Long-term safety and effectiveness follow-up study of AB-1005 gene therapy in patients with Parkinson’s disease or multiple system atrophy

    Not yet recruiting

    3 1 1
    Poland